NIPD Genetics
Business Services · Cyprus · 51-200 Employees
View Company Info for Free
Overview
Headquarters
31 Neas Egkomis, Nicosia, Nicosia, 2409,...Phone Number
+357 22266888Website
www.nipd.comRevenue
$16.9 MillionIndustry
About NIPD Genetics
Is NIPD Genetics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
NIPD Genetics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if NIPD Genetics has recently received funding, and reach out quickly before it becomes old news!
Click to see if NIPD Genetics had a recent Job posting/layoffs
Earning: See what the market has to say on NIPD Genetics recently announced quarterly report
Funding: Get notified immidiatlly once NIPD Genetics has new funding data
Product Launch: Get notified when NIPD Genetics launches new products
Congratulate Masked Content for being promoted to Masked Content at NIPD Genetics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if NIPD Genetics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
NIPD Genetics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
NIPD Genetics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about NIPD Genetics.
NIPD Genetics Tech Stack
A closer look at the technologies used by NIPD Genetics
NIPD Genetics News & Media
Medicover to Buy €44.4M in NIPD Shares, Acquire Majority Stake | Genomeweb
In 2018, NIPD struck a partnership deal with Medicover that included an equity investment and R&D cooperation.Increased ownership in NIPD Genetics
Medicover AB (publ) (“Medicover (http://www.medicover.com)”) has committed to acquire shares from existing shareholders and thereby increase its ownership in NIPD Genetics (“NIPD”) from 18.9 per cent to 87.2 per cent. The transaction is subject to customary merger control approvals and closing is expected in Q1 2022. Purchase price for the 68.3 per cent of acquired shares amounts to EUR 44.4 million with no debt assumed, implying an enterprise value of EUR 65.0 million. The acquisition will be
Top Business Services Companies
Frequently Asked Questions Regarding NIPD Genetics
NIPD Genetics is a leading innovative biotechnology company active in the field of developing, engineering and providing in vitro genetic testing solutions. NIPD Genetics was founded in 2010 to commercialize pioneering research work in the field of genetic testing. NIPD Genetics applies its proprietary genetic and bioinformatic analysis tools to de... Read More